Illumina, Inc. (ILMN)
206.45
+5.18
(+2.57%)
USD |
NASDAQ |
Sep 11, 16:00
205.66
-0.79
(-0.38%)
After-Hours: 05:59
Illumina Market Cap : 31.17B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 31.17B |
| September 10, 2026 | 30.39B |
| September 09, 2026 | 30.96B |
| September 08, 2026 | 31.87B |
| September 04, 2026 | 32.95B |
| September 03, 2026 | 33.47B |
| September 02, 2026 | 32.20B |
| September 01, 2026 | 31.28B |
| August 31, 2026 | 32.26B |
| August 28, 2026 | 32.55B |
| August 27, 2026 | 34.38B |
| August 26, 2026 | 33.95B |
| August 25, 2026 | 33.97B |
| August 24, 2026 | 33.71B |
| August 21, 2026 | 33.13B |
| August 20, 2026 | 32.20B |
| August 19, 2026 | 30.96B |
| August 18, 2026 | 28.43B |
| August 17, 2026 | 29.16B |
| August 14, 2026 | 28.82B |
| August 13, 2026 | 29.09B |
| August 12, 2026 | 29.13B |
| August 11, 2026 | 29.12B |
| August 10, 2026 | 28.96B |
| August 07, 2026 | 28.38B |
| Date | Value |
|---|---|
| August 06, 2026 | 29.25B |
| August 05, 2026 | 30.18B |
| August 04, 2026 | 30.65B |
| August 03, 2026 | 29.92B |
| July 31, 2026 | 30.97B |
| July 30, 2026 | 30.97B |
| July 29, 2026 | 29.42B |
| July 28, 2026 | 29.14B |
| July 27, 2026 | 28.80B |
| July 24, 2026 | 29.50B |
| July 23, 2026 | 29.92B |
| July 22, 2026 | 29.01B |
| July 21, 2026 | 29.26B |
| July 20, 2026 | 28.07B |
| July 17, 2026 | 28.37B |
| July 16, 2026 | 28.92B |
| July 15, 2026 | 28.45B |
| July 14, 2026 | 29.06B |
| July 13, 2026 | 28.89B |
| July 10, 2026 | 28.91B |
| July 09, 2026 | 29.45B |
| July 08, 2026 | 28.55B |
| July 07, 2026 | 29.15B |
| July 06, 2026 | 29.54B |
| July 02, 2026 | 28.68B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Thermo Fisher Scientific, Inc. | 225.48B |
| Agilent Technologies, Inc. | 41.43B |
| Danaher Corp. | 140.68B |
| Pacific Biosciences of California, Inc. | 404.05M |
| Bio-Rad Laboratories, Inc. | 9.875B |
Market Cap Related Metrics
| PE Ratio | 38.48 |
| PS Ratio | 7.062 |
| Price to Book Value | 10.98 |
| Price to Free Cash Flow | 62.12 |
| Price | 206.45 |
| Earnings Yield | 2.60% |
| Operating PE Ratio | 35.54 |
| Normalized PE Ratio | 44.00 |